THG1L
protein-codingtRNA-histidine guanylyltransferase 1 like
Gene summary
The protein encoded by this gene is a mitochondrial protein that is induced by high levels of glucose and is associated with diabetic nephropathy. The encoded protein appears to increase mitochondrial biogenesis, which could lead to renal fibrosis. Another function of this protein is that of a guanyltransferase, adding GMP to the 5' end of tRNA(His). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2015]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~10.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0032923
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0032923
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0032923
Submitter: ClinGen
tRNA-histidine guanylyltransferase 1-like protein (THG1L) was first reported in relation to autosomal recessive spinocerebellar ataxia in 2016 (Edvardson et al., PMID: 27307223). Cases with *THG1L* variants have been reported with a variety of phenotypes that can include but are not limited to: cerebellar ataxia, cerebellar atrophy or hypoplasia, global developmental delay, and seizures. Dysmorphic features like microcephaly and micrognathia have been reported but in a minority of cases. Five variants (4 missense and 1 splice-region) that have been reported in eight probands in five publications (PMIDs: 27307223, 30214071, 31168944, 33682303, 37670026) are included in this curation. Two families were observed with variation in *THG1L* where an ataxia-like disease segregated with the variants (PMIDs: 27307223, 33682303). The mechanism of pathogenicity is unclear but thought to be loss of function leading to abnormalities in mitochondrial localization and morphology (PMID: 27307223). No conclusive experimental evidence was found to support this gene-disease relationship in a literature review. In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the ClinGen Cerebellar Ataxia GCEP on the meeting date September 10, 2025 (SOP Version 11).
Inheritance Pattern: AR
Disease ID:MONDO:0032923
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0032923
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Musculoskeletal; Neurologic; Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to THG1L variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_017872.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 4 | ||||
| missense | 3 | 53 | 2 | 58 | ||
| nonsense | 1 | 2 | 3 | |||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 1 | 4 | 5 | |||
| Total | 1 | 4 | 59 | 6 | 0 | 70 |
Highest pathogenic variant AF is 0.000099959514
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_060342.2 | 6 | MANE Select | |
| Ensembl | ENSP00000231198.7 | 6 | MANE Select | |
| RefSeq | NP_001304753.1 | 5 | Standard | |
| RefSeq | NP_001304754.1 | 4 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- tRNA modification in the nucleus and cytosol
- tRNA processing
- Metabolism of RNA
Biological Process
- tRNA modification
- tRNA processing
- protein homotetramerization
- tRNA 5'-end processing
Molecular Function
- tRNA binding
- magnesium ion binding
- protein binding
- ATP binding
- GTP binding
Cellular Component
- mitochondrion
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000231198
- Coding exons
- 6
- Length
- 10252
- Individuals with no LoFs
- 125721
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 27
- Defined
- 125748
- p
- 0.000107
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.0266 | 169 | 170 | 0.994 | 0.00000881 | 1988 |
| Missense (PolyPhen) | 59 | 65.002 | 0.90766 | 715 | ||
| Synonymous | -0.590 | 69 | 63.0 | 1.09 | 0.00000349 | 535 |
| Loss of Function | 1.48 | 9 | 15.2 | 0.591 | 7.29e-7 | 173 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00025 | 0.00025 | rare |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00019 | 0.00017 | rare |
| South Asian | 0.00014 | 0.00013 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Adds a GMP to the 5'-end of tRNA(His) after transcription and RNase P cleavage. This step is essential for proper recognition of the tRNA and for the fidelity of protein synthesis. {ECO:0000269|PubMed:21059936}.;
Recessive Scores
- pRec
- 0.107
Intolerance Scores
- LoFtool
- 0.727
- RVIS EVS
- -0.25
- RVIS percentile EVS
- 35.75
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- H
- Indispensability pred.
- E
- Indispensability score
- 0.903
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |